Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Kering crawled date : 2022 - 02 - 23 save search
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Published: 2022-02-23 (Crawled : 22:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -8.77%
H: 6.66%
C: 5.47%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -5.49%
H: 3.87%
C: 3.65%
PCVX | $60.82 0.33% 0.33% 1.3M
|
Health Technology
|
| O: -8.4%
H: 22.28%
C: 21.9%
STRO | $3.635 -3.58% -3.71% 520K
|
Health Technology
|
| O: -1.09%
H: 8.21%
C: 8.09%
vax-24 disease phase 1 pneumococcal
AOTMP® Announces Women in Technology Focus in June Industry Publication
Published: 2022-02-23 (Crawled : 17:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 7.45%
H: 0.0%
C: -3.02%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 0.24%
H: 0.09%
C: -2.73%
aotmp technology women publication
Ballard & ABB Receive Approval in Principle for High-Power Fuel Cell Concept to Power Ships
Published: 2022-02-23 (Crawled : 14:00) - prnewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 7.45%
H: 0.0%
C: -3.02%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 0.24%
H: 0.09%
C: -2.73%
BLDP | $2.64 -1.86% -1.89% 2.4M
|
Producer Manufacturing
|
| O: 2.43%
H: 2.21%
C: -4.63%
fuel cell approval cel
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.